Concepedia

Ryan Lena

RL

6

Publications

344

Citations

6

H-Index

1997

Active since

Affiliations

Eutropics Pharmaceuticals (United States)(Current)

The University of Texas MD Anderson Cancer Center

Translational Genomics Research Institute

Ryan Lena is an author at Eutropics Pharmaceuticals (United States) specializing in pharmacotherapy, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

1997–2014

6

Publications

6

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies

James M. Bogenberger, Steven M. Kornblau, William E. Pierceall et al. · Leukemia · 2014 · 193 citations · Full text

, , +16

Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker

David J. Richard, Ryan Lena, Thomas D. Bannister et al. · Bioorganic & Medicinal Chemistry · 2013 · 54 citations · Full text

, , +9

Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response

Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone et al. · Molecular Cancer Research · 2014 · 43 citations · Full text

BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia

William E. Pierceall, Steven M. Kornblau, Nicole E. Carlson et al. · Molecular Cancer Therapeutics · 2013 · 32 citations · Full text

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia

William E. Pierceall, Ryan Lena, Bruno C. Medeiros et al. · Leukemia Research · 2014 · 12 citations · Full text

, , +11

Rows per page

1–5 of 6